Long-term real-world outcomes of nusinersen treatment in patients with spinal muscular atrophy types I–III
Brain & Development
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Педиатрия, перинатология и детское здоровье»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
Long-term real-world outcomes of nusinersen treatment in patients with spinal muscular atrophy types I–III. // Brain & Development. – URL: https://www.sciencedirect.com/science/article/pii/S0387760426001026?dgcid=rss_sd_all
Long-term real-world outcomes of nusinersen treatment in patients with spinal muscular atrophy types I–III. Brain & Development. https://www.sciencedirect.com/science/article/pii/S0387760426001026?dgcid=rss_sd_all
“Long-term real-world outcomes of nusinersen treatment in patients with spinal muscular atrophy types I–III.” Brain & Development.
@article{article38838,
title = {Long-term real-world outcomes of nusinersen treatment in patients with spinal muscular atrophy types I–III},
journal = {Brain \& Development},
url = {https://www.sciencedirect.com/science/article/pii/S0387760426001026?dgcid=rss_sd_all}
}